Chemoinformaics analysis of (4-PROPAN-2-YLPHENYL)METHYL ACETATE
| Molecular Weight | 192.258 | nRot | 3 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 18 |
| Exact Molecular Weight | 192.115 | nRing | 1 |
| Solubility: LogS | -3.686 | nHRing | 0 |
| Solubility: LogP | 3.376 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 32.3127 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.629 |
| Synth | 2.333 |
| Natural Product Likeliness | 1.235 |
| NR-PPAR-gamma | 0.957 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.861 |
| HIA | 0.031 |
| CACO-2 | -4.943 |
| MDCK | 0.0000115 |
| BBB | 0.006 |
| PPB | 0.960218 |
| VDSS | 0.582 |
| FU | 0.0657082 |
| CYP1A2-inh | 0.976 |
| CYP1A2-sub | 0.859 |
| CYP2c19-inh | 0.311 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.643 |
| CYP2c9-sub | 0.888 |
| CYP2d6-inh | 0.603 |
| CYP2d6-sub | 0.879 |
| CYP3a4-inh | 0.436 |
| CYP3a4-sub | 0.136 |
| CL | 6.807 |
| T12 | 0.839 |
| hERG | 0.042 |
| Ames | 0.596 |
| ROA | 0.043 |
| SkinSen | 0.934 |
| Carcinogencity | 0.11 |
| EI | 0.943 |
| Respiratory | 0.352 |
| NR-Aromatase | 0.884 |
| Antiviral | No |
| Prediction | 0.662128 |